Author:
Ali Syed Shaukat,Bahadar Haji,Shah Haseenullah,Ali Sajid,Khan Monasib,Khuda Fazli,Ijaz Kiran,Raziq Mohsin,Zakiullah .
Abstract
Objective: To evaluate the association of the SLC30A8 rs13266634 variant with Type 2 Diabetes Mellitus (T2DM) susceptibility among patients in Khyber Pakhtunkhwa, Pakistan. Methods: A case-control study design was employed involving 100 each T2DM patients and healthy controls. Demographic and clinical features were recorded. The SLC30A8 rs13266634 variant was genotyped using PCR-RFLP. Statistical analyses, including binary logistic regression, were conducted to determine the association between the variant and T2DM, adjusting for age, gender, family history, and lifestyle factors. Results: The study cohort comprised predominantly males (65% in cases, 75% in controls) with a mean age of 53±9 years. T2DM patients exhibited a higher prevalence of concurrent conditions such as high blood pressure compared to controls. Genotyping revealed a significant association of the rs13266634 variant allele with T2DM. Individuals carrying variant CT and TT genotype had a 2.12 times higher risk (95% CI: 1.16-4.12, P=0.025) of T2DM compared to that of wild CC type. This association remained significant upon adjustment for confounders, with an adjusted odds ratio of 2.890 (95% CI: 2.233-9.76, P=0.02) for CT carriers. Conclusions: The rs13266634 variant in the SLC30A8 is significantly associated with an increased risk of T2DM in the Khyber Pakhtunkhwa population
Publisher
CrossLinks International Publishers
Reference21 articles.
1. Mukhtar Y, Galalain A, Yunusa U. A modern overview on diabetes mellitus: a chronic endocrine disorder. European Journal of Biology. 2020 Nov; 5: 1-4. doi:10.47672/ejb.409.
2. da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, Guariguata L, Seuring T, Zhang P, Cavan D, Makaroff LE et al. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Research and Clinical Practice. 2016 Jul; 117: 48-54. doi: 10.1016/j.diabres.2016.04.016.
3. Peixoto-Barbosa R, Reis AF, Giuffrida FM. Update on clinical screening of maturity-onset diabetes of the young (MODY). Diabetology & Metabolic Syndrome. 2020 Dec; 12: 1-4. doi: 10.1186/s13098-020-00557-9.
4. Hilawe EH, Yatsuya H, Kawaguchi L, Aoyama A. Les différences entre les sexes dans la prévalence du diabète sucré, de la glycémie à jeun anormale et de l'intolérance au glucose en Afrique subsaharienne: Examen Systématique et Méta-Analyse. Bulletin of the World Health Organization. 2013 Sep; 91: 671-82D.
5. Dall TM, Yang W, Gillespie K, Mocarski M, Byrne E, Cintina I, Beronja K, Semilla AP, Iacobucci W, Hogan PF et al. The economic burden of elevated blood glucose levels in 2017: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care. 2019 Sep; 42: 1661-8. doi.10.2337/dc18-1226.